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Protein-protein interactions are vital in maintaining proper function and 
homeostasis in cells. Some signaling pathways are regulated by G-proteins that work like 
switches to activate and deactivate pathways. Mutations in these proteins, their effectors 
or the interaction between proteins may cause dysregulation of signals that can lead to 
many diseases. 
Rheb, Ras homology enriched in brain, is a Ras family GTPase that is vital in 
regulation of the mTOR (mammalian target of rapamycin) pathway that signals cell 
proliferation and growth. Due to the low intrinsic GTPase activity of Rheb, a GTPase 
activating protein (GAP), Tuberous Sclerosis Complex 2 (TSC2) down regulates Rheb by 
enhancing its GTPase activity. Currently, very little information is available about TSC2 
structures and the molecular details of the interaction between the two proteins. We 
explored various biochemical and biophysical information of Rheb-TSC2 interaction. In 
addition, we characterized the stability of the variant, TSC2-218 (D74A), using a 218 
amino acid truncated construct of TSC2, and the effects of the single point mutation on 
the interactions with Rheb. In comparison to the WT, the D74A variant showed to 
maintain protein stability (thermal and chemical), an increase in secondary (alpha helical) 
structure, binding and GAP activity towards Rheb. 
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CD Circular Dichroism 
CV Column Volume 
DSC Differential Scanning Calorimetry 
DNAse Deoxyribonuclease I (Bovine pancreas) 
EDTA Ethylenediaminetetraacetic acid 
Fd Fraction Denatured 
Ff Y-axis final value in plot of denaturation studies 
Fi Y-axis initial value in plot of denaturation studies 
FPLC Fast protein liquid chromatography 
GAP GTPase activating protein 
GDP Guanosine diphosphate 
GEF Guanine nucleotide exchange factor 
GMPPNP Guanosine 5′-[β,γ-imido]triphosphate (GTP analog - non-hydrolyzable) 
GST-tag Glutathione-S-Transferase - tag (affinity chromatography) 
GTP Guanosine triphosphate 
GTPase Protein that hydrolyzes GTP to  GDP 
His6-tag Hexa-histadine  - tag (affinity chromatography) 
IPTG Isopropyl-β-D-thiogalactoside 
ITC Isothermal titration calorimetry 
LB Lysogeny Broth 
mTOR mammalian target of rapamycin 
NMR Nuclear magnetic resonance 
PBS Phosphate buffered saline  
PDB Protein Data Bank 
Pi Inorganic phosphate 
PMSF phenylmethylsulfonyl fluoride 
Rheb Ras homology enriched in brain 
SDS Sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TSC Tuberous sclerosis complex 
tsc1, TSC1 tuberous sclerosis complex 1 (gene), tuberous sclerosis complex 1 
(protein)  
tsc2, TSC2 tuberous sclerosis complex 2 (gene), tuberous sclerosis complex 2 
(protein) 
TSC2-218 Small, truncated 218 amino acid construct of Tuberous sclerosis complex 
2, corresponds to residues (1525-1742) 
TSC2-218 
(D74A) 
Small, truncated 218 amino acid construct of Tuberous sclerosis complex 
2, corresponds to residues  (1525-1742) with an aspartic acid to alanine 
mutation at position 74 (position 1598 in full-length) 






I. Chapter 1: Introduction 
1.1 mTOR, Ras, GEF and GAP 
Protein-protein interaction and signaling are the basis for many biochemical processes in 
cells. To maintain proper function of metabolic activity, signaling pathways are often regulated 
by proteins. Any dysregulation of the pathways can lead to improper downstream activity and 
disease states. 
Ras superfamily of G-proteins are a class of highly conserved GTPases that act as 
switches in various signaling pathways by cycling nucleotides to activate or deactivate the 
pathways (1). When the protein is bound to GTP (guanosine triphosphate), the protein is 
biologically active; whereas, when bound to GDP (guanosine diphosphate), the protein is 
inactive (1).  
GTPases are able to intrinsically hydrolyze GTP (active) to GDP (inactive) + Pi 
(inorganic phosphate). Therefore, GTPases interact with effectors (guanine exchange factors and 
GTPase activating proteins) that enable nucleotide cycling and hydrolysis (Figure 1).  
 
Figure 1. Schematic of GTPase protein cycling between active (GTP-bound) and inactive (GDP-
bound) states and the roles of guanine exchange factors (GEFs) and GTPase activating proteins 




Guanine exchange factors (GEFs) bind to GDP-bound GTPase and stimulate the release 
of GDP, thus allowing the attachment of GTP (found in high concentrations in the cell). This 
establishes the protein to switch from an inactive to active state and furthers the signal 
downstream. When the biologically active protein is no longer required, GTP hydrolysis 
necessary to turn the signal off. This is accomplished by effectors known at GTPase activating 
proteins (GAPs). GAPs bind to GTPase proteins (GTP-bound and active) and promote GTP 
hydrolysis to GDP + Pi; thus, the protein is no longer active and the signal downstream is halted.  
Small GTPases from the Ras superfamily, specifically Rheb and Rag, are commonly 
known to regulate mTOR pathway (39). The mTOR, mammalian target of rapamycin, pathway is 
a vital signaling pathway which regulates cell growth and proliferation by promoting protein, 
lipids and nucleic acid synthesis (3). mTOR is a serine/threonine kinase that is comprised of 2 
functionally different complexes; mTOR complex 1 (mTORC1) and mTOR complex 2 
(mTORC2). mTORC1 (referred to as Raptor) is sensitive to rapamycin, whereas, mTORC2 is 
(referred to as Rictor) is resistant to rapamycin (4) (5) (6). Both mTORC1 and mTORC2 act as 
scaffolding proteins and they recruit and interact with many regulatory proteins. While mTORC1 
functions in protein synthesis via S6K and 4EBP1, mTORC2 centers on phosphorylation of Akt 
in presence of insulin (7).  
Normally, the kinase activity of mTORC1 and mTORC2 towards 4E-BP1 and Akt, 
respectively, are minimal (7). Active Rheb enhances kinase activity of mTORC1, and thus, 
increases the amount of phosphorylated 4E-BP1 (substrate of raptor/ mTORC1) in vitro (7) (8). 
However, Rheb does not augment kinase activity in mTORC2 toward Akt (7) (8). Within the Ras 
family, Rheb, unlike K-Ras, RalA, RalB and Rad proteins, was the only g-protein to exhibit 




mTORC1 (7). Due to the importance of the mTOR pathway in maintaining homeostasis, 
dysregulation of signaling can cause various human diseases such as cancers, obesity, diabetes 
(9) (10).  
1.2 Rheb 
Rheb, Ras homology enriched in brain, is a small 20kDa GTPase in the Ras superfamily 
of GTPases that was first identified in neural tissues primarily in the brain (11).  
Many sequences of Rheb are homologous (about 30-45% sequence) with other small 
GTPases, primarily Ras/Rap subfamily  (11). The 5 regions, G1-G5 which are specific to GTP 
binding, contain the highest homology between Rheb and its corresponding Ras family proteins 
(11). Structural comparisons also confirm that Rheb is most closely related to the Ras and R 
family than RhoA and Rab5A (12). 
Rheb and other small GTPases have 3 main regions: Switch I (residues 33-41), Switch II 
(residues 63-79) and P loop, each with distinct characteristics (12) (13) (14). Switch I of small 
GTPases are vital in identifying and interacting with their effectors; therefore, any variation in 
primary sequences and/or structures of the Switch I region contributes to the specificity of small 
GTPases to the corresponding effectors (12). The Switch I sequence of Rheb has high flexibility, 
like that of other GTPases (most similar to Ras and Rap). Structural comparison of the Switch I 
region also confirmed higher similarity to Ras and Rap than Rho and Rab, in respect to 
complexes with nucleotides (GDP, GTP, GTP analog) (12).  
The Switch II region displays major differences between small GTPases and Rheb (12). 
Typically, the Switch II region of small GTPases have an alpha helical conformation when 
complexed with GTP (or GTP analog), but assume a slightly disordered conformation at the N-




region undergoes a drastic conformational change in most GTPases. In contrast, in GTP-bound 
Rheb, the Switch II region is in an unraveled conformation rather than the typical alpha helical 
conformation as seen in GTPases. Hydrophobic and hydrophilic interactions between key 
residues in the N-terminal and C-terminal of the Switch II region appear to stabilize the 
conformation in Rheb (12). Interestingly, Yu et. al. found that the Switch II region of Rheb 
undergoes minimal conformational changes while cycling between GTP and GDP. Also, Switch 
II residue Gln64 is slightly displaced compared to the corresponding Ras (Gln61) and Rap 
(Thr61) residues (12). In addition, they found that this polar side chain is positioned away from 
the GTP-binding site and buried in a hydrophobic pocket (12). This leads to a lack of interaction 
with GTP, water molecules or nearby catalytic site residues. Further, Ras proteins normally 
contain a conserved Gly12 in the P loop; in contrast, Rheb has an arginine (R15) and serine 
(S16) that bind to GDP or GTP (13) (16) (17). The distinct and stable conformormation of Rheb, 
the inability of residue Gln64 to participate in GTP hydrolysis (unlike Ras counterpart, Gln61) 
and arginine and serine in lieu of glycine in the P loop, are thought to be the primary reasons for 
Rheb’s low intrinsic GTPase activity.  
 Data has consistently shown that Rheb has a low intrinsic GTPase activity, which is 
uncharacteristic of most GTPases, and is found in a constitutively active (GTP-bound) state (18) 
(19). Therefore, there is a vital need for down regulation of Rheb via protein-protein interaction 
to prevent consequences of overactive signaling of the mTOR pathway. This is achieved by 
TSC1-TSC2 complex which acts as a GTPase-activating protein for Rheb and enhances Rheb’s 
ability to undergo GTP hydrolysis in order to return to an inactive GDP-bound state (20) (21) 





TSC1 and TSC2 (tuberous sclerosis complex 1 and 2) are proteins derived from tsc1 and 
tsc2 genes (25) (26). These genes were first identified as tumor suppressor genes (27). Mutations 
found in Tsc1 or Tsc2 genes can cause an autosomal dominant disorder known as tuberous 
sclerosis (28) (29). This disease state causes various benign tumors (hamartomas) throughout the 
body and at times, neurological symptoms (28) (29). 
TSC1, also referred to as hamartin (140kDa), and TSC2, as tuberin (200kDa), form a 
heterodimer, known as the tuberous sclerosis complex (TSC) (25) (26). TSC is found in many 
areas throughout the body including the brain, kidneys, heart, liver, pancreas and other organs 
(30).  
Studies have shown that the GAP domain at the C-terminal of TSC2 is highly conserved 
and homologous to the Rap1GAP (31) and is able to down-regulate Rheb by enhancing its 
GTPase activity (28). Specifically, mutations in this TSC2 GAP domain have resulted in a loss 
of down-regulation of S6K and 4EBP1 (regulatory proteins activated directly by mTORC1) due 
to loss of Rheb GTPase activity (21) (28). Interestingly, the C-terminus mutations did not affect 
the interaction of TSC2 with TSC1 and only with Rheb (27). In addition, TSC1 does not seem to 
alter GTPase activity of Rheb (32). A smaller 400 residue C-terminal construct of TSC2 is 
unable to bind to TSC1, but still activates GTP hydrolysis in Rheb (32). In 2009, Marshall et. al, 
used an even smaller truncated version of the C-terminal of TSC2 (TSC2-218) to observe the 
GAP stimulated GTPase activity of Rheb using Real-Time NMR (33). This 218 amino acid 
truncated version included the GAP domain of TSC2-218 and was still able to maintain GAP 





Figure 2A. Schematic of the interaction between TSC2-218 (truncated construct of TSC2) and 
Rheb and the down stream regulation of mTOR pathway. GTP, GDP, Rheb-GTP (1XTS.pdb) 
and Rheb-GDP (1XTQ.pdb) structures were obtained through Protein Databank. TSC2-218 WT 
was predicted using I-TASSER (35) (36)  (37) (38). Schematic was made using PowerPoint. 
 
Though Rheb has been studied extensively, there is relatively very little information 
about its interaction mechanism with TSC2 and the structural characteristics of TSC2. In fact, 
there is no known full structure of the TSC2 protein. By studying single point mutations in key 
regions of TSC2, importance of corresponding residues on TSC2 in interactions with Rheb may 
be better understood.  
Marshall and colleagues used Real-Time NMR to observe the distinct structural changes 
induced by nucleotide dependent conformations to study GTPase activity of Rheb in the 
presence of TSC2-218 (a 218 amino acid construct from residues 1525 to 1742) and mutations 
(33). In this study, single point mutations were created in residues that were involved in tuberous 




Most mutations in the TSC2-218 GAP catalytic and binding regions showed similar 
decrease in GTPase activity as the Rap1GAP homologs, however, there were significant 
differences in the adjacent and partially conserved regions (28) (33).  
The focus of this project will be to study one such mutation (TSC2-218 D74A) that is 
found in the region adjacent to the catalytic core of TSC2. The corresponding mutation showed 
an elimination of GAP activity in the homologous RAP1GAP, but not in TSC2 (28) (33). It is 
possible that the D74A mutation is able to stabilize the interaction with Rheb (unlike other GAP 
mutations in Ras proteins) and maintain GTPase function of Rheb as suggested in Figure 2B. 
The truncated 218 amino acid construct of TSC2, TSC2-218, will be used to observe the 
characteristics of the TSC2 single point mutation, D74A, and its interaction with Rheb. 
 
Figure 2B. Schematic of the interaction between TSC2-218 D74A (truncated construct of TSC2)  
and Rheb and the down stream regulation of mTOR pathway. Rheb-GTP (1XTS.pdb) and Rheb-
GDP (1XTQ.pdb) structures were obtained through Protein Databank. TSC2-218 D74A structure 
was predicted using I-TASSER (35) (36) (37) (38). Schematic was made using PowerPoint 
 
II. Chapter 2: Experimental Methods 
2.1 Protein Over-Expression and Purification 
2.1.1 Rheb 
 Ras homology enriched in brain (Rheb) proteins were over-expressed as His6-tagged (6 
histidine residues) fusion proteins and purified using affinity chromatography on a Ni2+ column. 
Rheb was incorporated into the plasmid vector, pET15b, in the Escherichia coli (E. coli) strain 




subsequent over-expression procedures. 1 mL of the pre-existing stocks were added to flasks 
containing 100mL of LB broth media and 100uL ampicillin and incubated in the shaker at 37°C 
overnight (between 12 to 16 hours). The next morning, the seed cultures were inoculated into 6L 
Erlenmeyer flasks containing 1.5L LB broth and 750uL ampicillin and allowed to grow on the 
shaker at 37°C. The OD (optical density) was measured using a UV-Vis spectrometer at 600nm 
every hour until the culture reached the target OD of 0.6-0.8. Once in this range, the culture was 
then induced with 0.5mM IPTG and kept in the shaker at 37°C for four hours. To harvest the 
cells containing our target protein, each flask was centrifuged at 6,500 rpm for 20min at 4°C. 
The supernatant was discarded and the pellet was collected and resuspended in 10mM Tris pH 6. 
The resuspended pellet was then centrifuged at 5,000 rpm for 12-15min at 4°C. The supernatant 
was discarded and the pellet was stored in -80°C until purification.  
 Before purification, the pellet was thawed on ice and then resuspended in lysis buffer 
containing 45mg lysozyme, 150uL halt protease, 1mM PMSF and DNAse. The cells were 
sonicated on ice for 10 seconds on followed by 10 seconds of rest for a total of 20 minutes. The 
lysed sample was then centrifuged for 20min at 18,500 rpm at 4°C. The supernatant was 
collected and subsequently filtered. The sample was then loaded into an FPLC (Fast protein 
liquid chromatography) machine and purified using affinity chromatography protocols for His6-
tagged proteins using a 5ml pre-packed Ni2+ column.  
 PBS Ni2+ binding buffer (PBS pH 8.0, 25mM imidazole and 50mM MgCl2) and PBS 
Ni2+ elution (PBS pH 8.0, 400M imidazole and 50mM MgCl2) were made and filtered prior to 
purification. The 5ml pre-packed Ni2+ column was stripped of any residual particles and 
regenerated with buffers containing nickel. The FPLC machine was washed with autoclaved and 




equilibrated with binding buffer. The protein sample and binding buffer were loaded onto the 
Ni2+ column. The proteins lacking His6-tag would flow through the column and the target Rheb 
protein (His6-tag fusion protein) would bind to the column. Then, increasing amounts of elution 
buffer were loaded on the column and at approximately 245-250mM imidazole concentration, 
Rheb would elute. Rheb samples were collected in fractions according to the presence of peaks 
on the chromatogram. The fractions were collected and band size and purity were confirmed 
using SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis). The band size 
was confirmed against a molecular weight ladder and purity was established by lack of 
appearance of other bands on the gel (Figure 3), the protein sample was dialyzed in Tris pH 8.0 
at 4°C overnight (12-16 hours).  
 If the experiment required Rheb to be active, but unable to undergo intrinsic GTPase 
hydrolysis, then the sample was subjected to nucleotide exchange in which a nonhydrolyzable 
GTP analog (GMPPNP) was attached. In this procedure, Rheb was incubated for 1 hour at 4°C 
with 5mM GTP analog and 5mM EDTA. A desalting column (PD-10) was equilibrated with 5 
column volumes of Tris buffer prior to loading the protein sample. Fraction were collected and 
tested with Bradford assay reagent to determine the presence of proteins. The target fractions 
were then collected combined and 10mM MgCl2 was added. Purified, and if required, nucleotide 
exchanged, Rheb protein samples were either immediately stored in -80°C freezer or lyophilized 





Figure 3. SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) of a sample 
purification of His6-tagged fusion protein, Rheb. The lysate contains all proteins expressed in E. 
coli cell, the flow through contains all proteins that do not bind to Nickel column. When loaded 
on the column, target His6-tagged protein, Rheb, will bind and at imidazole concentration of 
about 250mM, Rheb starts to elute. The fractions containing Rheb are collected. This gel 
confirms the size of the protein to be around 20 kDa which corresponds to the molecular weight 
of Rheb. In addition, there is a lack of additional bands seen in the gel which confirms the 
relative purity of the purified protein sample. 
 
2.1.2 TSC2-218 (WT) 
Tuberous sclerosis complex 2 construct with 218 amino acids (TSC2-218) proteins were 
GST-tagged fusion protein (contain glutathione-S-transferase tag at the N-terminus), over-
expressed and purified using affinity chromatography on a GST affinity column. GST-TSC2-218 
was incorporated into the plasmid vector, pET15b, in the Escherichia coli (E. coli) strain BL21 
(DE3) and over-expressed in LB broth. Glycerol stocks were previously made and used in 
subsequent growth/harvesting procedures similar to that of the Rheb listed above. Unlike for 
Rheb, TSC2-218 proteins were allowed to grow until reaching an OD600 of 0.9-1.0 before 
induction by 0.5mM IPTG, followed by 4.5 to 5 hours incubation in 37°C. Cells were harvested 
similarly to Rheb by centrifugation at 6,500rm for 20min at 4°C and the pellet was resuspended 
in 10mM Tris pH 6. The resuspended pellet was then centrifuged at 5,000 rpm for 12-15min at 




 Before purification, the pellet was thawed on ice and then resuspended in lysis buffer 
containing 45mg lysozyme, 150uL halt protease, 75ul PMSF and DNAse. The cells were 
sonicated, centrifuged and filtered in a similar fashion to Rheb. The sample was then loaded into 
an FPLC (Fast protein liquid chromatography) machine and purified using affinity 
chromatography protocols for GST-tagged proteins using a 5ml pre-packed GST affinity column.  
 Binding buffer containing 10mM PBS pH 7.4 and elution buffer containing 0.02mM Tris 
HCL and 10mM glutathione pH 8.0 (freshly prepared before each purification) were made and 
filtered prior to purification. The 5ml pre-packed GST affinity column was stripped using 6M 
guanidine hydrochloride, washed with water, regenerated with two rounds of 30-50ml of buffers 
1 (01M Tris and 0.5 M NaCl pH 8.5) and 2 (0.1 M sodium acetate and 0.5 M NaCl pH 4.5), and 
washed again with water. The FPLC machine lines were washed with water, binding and elution 
buffer, and the GST affinity column was equilibrated with binding buffer. The protein sample 
and binding buffer was loaded onto the GST affinity column where the GST tagged fusion 
protein (TSC2-218) would bind to the column (containing glutathione) and other proteins would 
flow through the column. When elution buffer prepared with 10mM glutathione, the protein 
would elute out in fractions that were then collected to be confirmed using SDS-PAGE (Figure 
4A). The sample was then dialyzed in PBS pH 7.4 at 4°C overnight (12-16 hours).  
 The next day, GST-tagged fusion protein, TSC2-218, underwent thrombin cleavage to 
cleave the GST tag (large, around 26kDa) from the protein. One unit of thrombin was added for 
every 100µg of protein and incubated for 1-2 hours at 4°C. About 75µl Halt protease inhibitor 
cocktail was then added to the mixture and the sample underwent a subsequent purification in 
order to remove GST from the protein sample. This purification is similar in procedure, however, 




flows through the column and is collected in fractions. The samples are then checked via SDS-
PAGE (Figure 4B) and dialyzed using PBS buffer pH 7.4 then subsequently stored at -80°C. 
 
Figure 4. SDS-PAGE gels of GST-TSC2-218 samples from the GST-fusion protein purification 
(A) and subsequent TSC2-218, target protein, purification (B). (A) Lane 1 contains molecular 
weight ladder, Lysate contains all proteins expressed by cell, Flow through contains proteins 
lacking the GST affinity tag. GST-TSC2-218 elutes with addition of Elution buffer (Glutathione 
concentration of 10mM) and fractions containing protein was collected (Protein Collections). (B) 
Cleaved protein includes all proteins after thrombin cleavage. Target TSC2-218 protein flows 
through the column and is collected. With the addition of elution buffer containing 10mM 
glutathione, GST elutes. Bands are checked on SDS-gel for size and purity. 
 
2.1.3 TSC2-218 (D74A) 
The procedure for the variant of TSC2-218, D74A, was almost identical to the wild-type. 
However, since there were no glycerol stocks of the variant available, plasmids for TSC2-218 
(D74A) were acquired and transformed with E. coli NEB 5-alpha strain for plasmid 
amplification. After transformation, the cells were plated in LB agar and allowed to grow 
overnight at 37°C. Plasmids were isolated from the culture and sequenced (at UAMS DNA 
Sequencing Laboratory in Department of Microbiology and Immunology) to check for correct 
genetic sequence. After confirmation the sequencing, plasmids were then transformed into E. 





Test expressions were performed on the over-expression of E. coli cells containing GST-
TSC2-218 (D74A) to optimize conditions to achieve best yields. Conditions that were 
specifically tested were the optimal OD600 range and amount of IPTG to induce cell cultures. 1ml 
of glycerol stocks were incubated in the shaker at 37°C in 10mL LB media in a 50m falcon tube 
with 10uL ampicillin overnight (12-16 hours). The next day, the 10ml cultures were added to a 
500ml Erlenmeyer flask containing 90ml LB media, 100uL ampicillin and incubated in the 
shaker at 37°C. OD600 (optical density at 600nm) readings were taken on the UV-Vis 
spectrometer every 15 min and recorded. Using Excel, the data was converted into a graph 
(Figure 5). The mid log phase was determined to be at around OD600 = 0.8-1.0. This was 
determined to be the optimal OD range (which was similar to the wild-type).  
 To confirm the proper absorbance and determine the optimal concentration of IPTG 
needed to induce higher yield of protein, 1 ml was taken from each sample at OD = 0.4, 0.6, 0.8 
and 1.0 and incubated with 0.5mM and 1.0mM IPTG and incubated in the shaker at 37°C for 4 
hours. Each 1ml sample was prepared for SDS-PAGE by being centrifuged at 13,000 rpm for 3 
minutes, the supernatant was removed, 15uL of 2X sample dye was added and the sample was 
heated for 5 minutes at 80°C. After 4 hours, another 1mL of each sample was placed into a 2ml 
centrifuge tube and the steps for sample preparation were repeated. The pre-induction, post 
induction and molecular ladder samples were all loaded onto a 15% polyacrylamide gels and 
SDS-PAGE was performed (Figure 6A). Band intensities were quantified using densitometry 
analysis using UN-SCAN- IT. As represented in Figure 6B, the values were then graphed using 
Excel. It was determined that the optimal OD range was around 1.00 and the 1mM IPTG was 
only yielded slightly higher band intensity than the 0.5mM so 0.5mM IPTG was used in 





Figure 5: Test expression for optimal optical density range (A600nm). An absorbance was 
measured every 15 minutes after inoculation. The data was then recorded and graphically 
















Figure 6A. Test expression for optimal OD and IPTG amount. Pre-induction and post-induction 
samples were collected, centrifuged, resuspended in sample dye and loaded onto a 15% 
polyacrylamide gel.  
 
 
Lane 1: MW Ladder 
Lane 2: OD 0.4 - Pre-Induction 
Lane 3: OD 0.4 - 0.5M IPTG 
Lane 4: OD 0.4 - 1.0M IPTG 
Lane 5: OD 0.6 - Pre-Induction 
Lane 6: OD 0.6 - 0.5M IPTG 
Lane 7: OD 0.6 - 1.0M IPTG 
Lane 8: OD 0.8 - Pre-Induction 
Lane 9: OD 0.8 - 0.5M IPTG 
Lane 10: OD 0.8 - 1.0M IPTG 
Lane 11: OD 1.0 - Pre-Induction 
Lane 12: OD 1.0 - 0.5M IPTG 








Figure 6B: Graphical representation of densitometric analysis of test expression for optimal 
optical density and IPTG concentration. Excel was employed to create this graph. 
 
2.2 Characterization Studies of TSC2-218 (WT) and TSC2-218 (D74A) 
2.2.1 Circular Dichroism Spectra 
 JASCO Corp., J-1500 Spectrometer was used to take circular dichroism measurements 
of purified protein samples of TSC2-218 (WT and D74A) in the far-UV range (190-250nm) 
using a 2mm pathlength Starna Cells quartz cuvette (Catalog Number: 3-Q-10). The protein 
concentration of the samples was diluted to 0.2mg/ml in 10mM phosphate buffer pH of 7.4). The 
spectra were measured at 50nm/min for each sample. A spectrum of a cell containing only buffer 
was recorded and subtracted from each sample measurement using Excel. Graphs of CD spectra 
measurements were obtained using Spectra Manager. 
2.2.2 Urea Denaturation 
Urea denaturation experiments were carried out using the JASCO Corp., J-1500 
Spectrometer in 300nm to 400nm range using 10mm pathlength Starna Cells quartz cuvette 
(Catalog Number: 9-Q-10). The purified samples of TSC2-218 (WT and D74A) were diluted to 




increasing concentration of 8 Molar (M) urea in autoclaved and filtered water. Urea was titrated 
using the Automatic Titration Scan measurement program from a range of 0M to 6.4M urea at 
25°C. A baseline buffer spectrum was subtracted from each spectrum using Excel and this 
experiment was 2-3 times for each construct of TSC2-218.  
To determine the ratio of unfolded protein (Fd) vs concentration of urea, the following 
equation (Equation 1) was used where Fi, Ff and F represent initial (native state) intensity, final 





2.2.3 Thermal Denaturation 
Thermal denaturation studies were carried out using JASCO Corp., J-1500 Spectrometer 
in the far UV CD (190nm-250nm) using 10nm pathlength Starna Cells quartz cuvette (Catalog 
Number: 3-Q-10). The purified samples of TSC2-218 (wild type and D74A) were diluted to 
0.28mg/ml in 10mM phosphate buffer pH of 7.4. A total of 14 spectra were recorded with 
increasing temperature from 25°C to 90°C. A baseline buffer spectrum was subtracted from each 
spectral value using Excel. This experiment was performed with 2-3 samples each and the data 
averaged for both TSC2-218 wild type and variant (D74A) samples. Excel was employed to 
calculate the ratio of unfolded protein versus temperature for each of the samples and graphically 
presented.  
2.3 Interaction Studies between RHEB and TSC2-218 (WT and D74A) 
2.3.1 Circular Dichroism Difference Spectra 
CD difference spectra measurements were also performed using JASCO Corp., J-1500 
Spectrometer in the far-UV CD range (190-250nm). The purified protein (Rheb) and effector 





buffer pH of 7.4, to maintain a ratio of 1:1. CD measurements of each sample were taken prior to 
incubation. Protein and ligand samples were then incubated together for 30 min at 4°C and CD 
measurements were gathered at 0 min and 30 min after incubation. The spectra were measured at 
50nm/min for each sample. A buffer spectrum was collected and subtracted from each sample 
spectra using Excel. TSC2-218 spectra were then subtracted from the mixture spectra using 
Excel and graphs of difference spectra were obtained using Spectra Manager and Excel.  
2.3.2 GTPase Hydrolysis Assay 
GTP hydrolysis assays were carried out using GTPase-Glo Assay Kit (Promega V7681) 
and white 384 Well Polystyrene Microplates (Greiner Bio-One Catalog # 781075) in order to 
observe differences in GTPase Activity in Rheb in the presence and absence of TSC2-218 (WT 
and D74A). After purification of the Ras GTPase (Rheb), nucleotide exchange with the 
nonhydrolyzable GTP analog was not performed. All samples of Rheb and its GAP effectors, 
TSC2-218 (WT and D74A), were dialyzed in PBS (pH 7.4) and samples were run on the gel to 
confirm the presence of protein prior to performing experiments. The protein samples were 
diluted in GTPase/GAP buffer (provided in kit) and luminescence was recorded using the 
BioTek Gen5 program and Synergy H1 Hybrid plate reader.  The relationship between GTP 






Figure 7. Schematic of Promega GTPase Activity Assay describing the procedure summary of 
GTPase reaction, incubation, and addition of Reagent 1 (GTPase-Glo Reagent) and Reagent 2 
(Detection Reagent).  
 
To observe Rheb’s intrinsic GTP hydrolysis activity, 5uL of Rheb (at various 
concentrations from 0uM to 4uM) and 1mM DTT was incubated for 90min at room temperature 
with 5uL of 10uM GTP (in GAP buffer). Then, 10uL of reconstituted Glo-GTPase Reagent 
(freshly made 15 min prior to use) was added to each reaction and incubated shaking at room 
temperature for 30min. Then, 20uL of detection reagent (provided in kit) was added to each well 
and incubated at room temperature for 5-10min and luminescence was recorded using Gen5 
program on the plate reader. The data was then exported to Excel and Origin and graphically 
presented 
Once the variables were optimized in multiple test experiments, GTPase Activity Assay 
was performed on 10µM Rheb (with 10mM Mg added) in the presence and absence of 2.25µM 
TSC2-218 WT and D74A in the following method, where Solutions 1 and 2 were prepared 




Table 2. Contents of the solution for each variable in the GTPase activity assay. Solution one 
was added to the wells first and then solution 2 was added to start the GTPase reaction.  
 Solution 1 Solution 2 
GTP Only 
1mM DTT in GTPase/GAP 
buffer 10uM GTP in GTPase/GAP buffer 
Rheb Only 10uM Rheb and 1mM DTT 10uM GTP in GTPase/GAP buffer 
Rheb + WT 
10uM Rheb and 1mM DTT in 
GTPase/GAP buffer 
2.25uM TSC2-218 (WT) and 10uM 
GTP in GTPase/GAP buffer 
Rheb + 
D74A 
10uM Rheb and 1mM DTT in 
GTPase/GAP buffer 
2.25uM TSC2-218 (WT) and 10uM 
GTP in GTPase/GAP buffer 
 
GAP concentration dependent studies were also performed using TSC2-218 (WT and 
D74A) concentrations from 0uM to 2.1uM in the presence of 10uM Rheb. The 0uM TSC2-218 
group represented the Rheb control group as it included only Rheb, GTP and all other buffers 
(and no GAP protein). A 10uM GTP only group was also tested and this luminescence value was 
used to represent the total GTP concentration in the solution. This experiment was repeated 2-4 
times for each sample. 
III.  Chapter 3: Results 
3.1 Characterization Studies of TSC2-218 (WT) and TSC2-218 (D74A) 
3.1.1 Circular Dichroism Spectra 
To observe the characteristic differences between TSC2-218 Wild-type and variant 
(D74A), experiments focusing on the structural, chemical and physical properties were 
performed.  
The secondary structural differences were compared by performing circular dichroism 
studies on TSC2-218 wild-type and variant (D74A). The CD spectra for the variant of TSC2-
218, D74A, is similar to that of wild-type (WT) (Figure 8). Specifically, there are noticeable 
negative peaks at approximately 208 and 223nm which correspond to those of standard alpha 





Figure 8: Circular Dichroism (CD) Spectra of TSC2-218 Wild Type (WT) and variant (D74A). 
Jasco Spectral Management was used to obtain CD spectra data and Excel was used to 
graphically present the molar ellipticity data for TSC2-218 wild-type and variant. 
 
3.1.2 Urea Denaturation 
To assess the protein stability of the TSC2-218 (D74A) in comparison to wild-type, urea 
denaturation experiments were performed. The presence of urea, a chemical denaturant, disrupts 
hydrogen bonding (found in secondary and tertiary structure of proteins) and in turn induces the 
protein to unravel. Thus, by increasing urea concentrations, the protein begins to unfold. This 
unfolding causes any hydrophobic tryptophan residues (intrinsic fluorophore) to be exposed 
which in turn show an increase in fluorescence intensity. TSC2-218 contains 2 tryptophan 
residues that act as intrinsic fluorophores. With increasing amounts of 8M urea being titrated into 
the protein samples, both TSC2-218 wild type and variant started to unfold. A raw data of the 
fluorescence spectra at 0M urea and 6.6M urea show a decrease in fluorescence, in addition to a 




Looking at Figure 9B (fraction denatured over urea concentration), initially (at low urea 
concentrations) the amount of unfolded protein of both WT and D74A slowly increases, then the 
protein sample contains mostly unfolded protein with a urea concentration of around 6.6M. 
Comparison of the averaged WT with the averaged values for the variant (D74A) shows an 
almost identical graph of protein unfolding (Figure 9B). However, since the urea denaturation 
plot does not seem to be completely denatured, the Y value from the fitted line in Figure 9B was 
used as the Ff value for Equation 1. All Fd values were re-adjusted to represent a more accurate 
fraction denatured versus urea concentration plot (Figure 9C). Cm values (the urea concentration 
at which half the protein is in an unfolded state and half is in the folded state) were calculated 
using the adjusted plot. Both TSC2-218 Wild-type and D74A both showed similar values for Cm 
(3.47M and 3.58M, respectively).  










Figure 9B. Fraction denatured (Fd) plot 
of TSC2-218 Wild-Type (WT) and 
variant (D74A) against urea 
concentration (M) using Equation 1. A 
total of 3 different samples were 
averaged each for TSC2-218 wild-type 
and variant using Excel and graphically 
presented above using Origin.  
 
Figure 9A. Fluorescence spectra of TSC2-
218 at native (0M Urea) and unfolded 
(6.6M Urea). There is a distinct decrease in 
fluorescence at 6.6M urea and a shift from 
max emission intensity at 338nm at native 
state and shift towards the right to 348nm 
for unfolded protein. Data was graphically 





Figure 9C. Urea Denaturation study data representing the adjusted ratio of denatured TSC2-218 
WT and variant (D74A) against the urea concentration (M) using Equation 1. Fd values were 
adjusted using the fitted value at 10M urea from Figure 9B. Cm values were then derived from 
this adjusted plot. 3 different samples were averaged each for TSC2-218 wild-type and variant 
using Excel and graphically presented using Origin. 
 
3.1.3 Thermal Denaturation 
Thermal denaturation studies can help assess the protein’s thermal stability, indirectly. As 
temperature increases, the protein denatures and begins to unfold due to the disruption of 
hydrogen bonds forming the secondary structure. As it unfolds, the protein will start to lose its 
secondary structure characteristics and can be observed using circular dichroism (CD). A thermal 
denaturation study will aid in determining if the protein stability varies due to an addition of a 
mutation (TSC2-218 (D74A)). As seen in Figure 10A, as the temperature increases, the fraction 
unfolded starts to increase. This represents a decrease in secondary structure. Thus, when looking 
at the ratio of folded to unfolded protein, the protein continues to unfold with increasing 
temperature until about 85°C when the protein seems to be mostly unfold (Figure 10A). 
Comparison of the averaged WT with the averaged values for the variant shows a very similar 
graph of protein unfolding (Figure 10A). However, the proteins were not completely 
unfolded/denatured. Therefore, the raw data for TSC2-218 WT and D74A spectra was graphed 




(where the protein is suggested to be completely unfolded/denatured) was used as the Ff value in 
Equation 1 in order to adjust the data to a more accurate fraction denatured plot. All measured 
values were then adjusted and Fd was plotted against temperature (Figure 10C). The Tm, 
temperature at which the Fd value is 0.5 (half unfolded), values for TSC2-218 WT and D74A 
were 69.55°C and 70.80°C, respectively.  
 
Figure 10A: Thermal Denaturation study data representing the ratio of denatured TSC2-218 
Wild-Type (WT) and variant (D74A) against the temperature (°C) using Equation 1. A total of 2-
3 different samples were averaged each for TSC2-218 wild-type and variant using Excel and 





Figure 10B: Raw averaged thermal denaturation data representing the adjusted ratio of denatured 
TSC2-218 Wild-Type (WT) and variant (D74A) against the temperature (°C) using Equation 1. 
In addition, Fd values were normalized to extrapolated data values at temperatures of 120, 130, 
140 and 150°C (obtained from fitted line from Figure 10B). A total of 2-3 different samples were 
averaged each for TSC2-218 wild-type and variant using Excel and graphically presented using 
Origin. 
 
Figure 10C: Thermal Denaturation study data representing the adjusted ratio of denatured TSC2-
218 Wild-Type (WT) and variant (D74A) against the temperature (°C) using Equation 1. In 
addition, Fd were normalized to extrapolated data values at temperatures of 120, 130, 140 and 
150°C (obtained from fitted line from Figure 10B). A total of 2-3 different samples were 






3.2 Interaction Studies between RHEB and TSC2-218 (WT and D74A) 
3.2.1 Circular Dichroism Difference Spectra 
Circular dichroism (CD) difference spectra were used to observe the changes to the 
structure of Rheb in the presence and absence of TSC2-2128 WT and D74A. If binding is 
present between two proteins, it can be observed by the change in secondary structure due to a 
conformational change upon binding. A CD spectrum was measured for each sample of Rheb 
(Blue line) and TSC2-218, WT and D74A (not present), then the proteins were incubated 
together and the spectra of the mixture was measured at 0 min and 30 min (Red line). The 
spectra of the TSC2-218 (WT and D74A) was mathematically subtracted from the mixture (Rheb 
and TSC2-218) to represent the structural characteristic of Rheb after incubation and possible 
interaction with TSC2-218 (Orange line). The change in circular dichroism spectra between 
Rheb (Blue line) and mathematically determined Rheb (Orange line) represents a conformational 
change. In both Figure 11A and Figure 11B, there is a difference in CD Spectra between Rheb 
and Corrected Rheb ((Rheb+TSC2-218 Mix spectra) – (TSC2-218 spectra)); therefore, both 





Figure 11A: Circular dichroism (CD) difference spectral data for Rheb in the presence and 
absence of TSC2-218 wild type (WT) was obtained using Jasco Spectra Measurement program. 
The data for wavelength vs CD intensity (millidegrees) of Rheb, TSC2-218 WT and Rheb 
incubated with TSC2-218 WT for 30min was exported and graphically presented using Excel. 
CD data for WT was then mathematically subtracted from incubated Rheb + TSC2-218 WT 
mixture to represent the Corrected Rheb CD spectra. 
 
Figure 11B: Circular dichroism (CD) difference spectral data for Rheb in the presence and 
absence of TSC2-218 variant (D74A) was obtained using Jasco Spectra Measurement program. 
The data for wavelength vs CD intensity (millidegrees) of Rheb, TSC2-218 (D74A) and Rheb 
incubated with TSC2-218 (D74A) for 30min was exported and graphically presented using 




3.2.2 GTPase Hydrolysis Assay 
Intrinsic GTPase activity assays are performed to observe a protein’s ability to undergo 
hydrolysis of GTP to GDP without the aid of any effectors. To determine the extent of intrinsic 
Rheb GTPase activity, various concentrations of Rheb was incubated with 10uM GTP (without 
any TSC2-218 GAP proteins) for 90 min and luminescence was measured. According to Figure 
12, as the concentration of Rheb increased, the luminescence decreased. However, there was 
very little difference between luminescence (which corresponds to the GTP concentration) at 
4uM and 0uM Rheb (Figure12).  
 
Figure 12. Graphical representation of intrinsic Rheb GTPase activity. Luminescence 
corresponds to the GTP concentration. Data was obtained using the Gen 5 program from BioTek 
and exported to Excel. The data was then plotted and fitted using Origin. 
 
TSC2-218 WT and variant (D74A) were incubated with Rheb and GTP for 90min and 
then the luminescence was measured in order to observe the GAP effect of TSC2-218 WT and 




Rheb + TSC2-218 D74A group had lower GTP concentration than Rheb and GTP only. In 
addition, Rheb + D74A group showed a slightly lower GTP concentration than Rheb + WT 
(Figure 13). 
 
Figure 13. Graphical representation of GAP (TSC2-218 WT and D74A) stimulated Rheb 
GTPase activity. GTP only and Rheb only were used as controls. Data was obtained using the 
Gen 5 program from BioTek and exported to Excel. The data was then plotted and fitted using 
Origin.  
 
To observe the effect of TSC2-218 WT and D74A concentration on GTPase activity of 
Rheb, increasing concentrations of TSC2-218 WT and variant (D74A) were incubated with Rheb 
and GTP for 90min and then the luminescence was measured. Figure 14 depicts that with 




addition, the WT and variant GAP proteins displayed very little difference between relative GTP 
concentrations at each concentration (Figure 14).  
 
Figure 14. Graphical representation of GAP concentration-dependent study of Rheb GTPase 
activity in the presence of WT and variant, D74A. GTP only was used to normalize the 
luminescence data for all samples. Data was obtained using the Gen 5 program from BioTek and 
exported to Excel. The data was then plotted and fitted using Origin.  
 
IV.  Chapter 4: Conclusions and Future Directions 
Ras superfamily GTPases are vital in regulating cell signaling and homeostasis. Rheb, the 
model Ras GTPase protein studied, signals the activation of the mTOR pathway that further 
activates cell division and growth. Due to its low intrinsic GTPase activity of Rheb, TSC2, a 
GAP protein, is needed to enhance Rheb GTP hydrolysis. Mutations in key residues in Rheb and 
TSC2 have been shown to disrupt the binding to, stability of, and/or enzyme activity of Rheb, 
leading to over stimulation of the mTOR pathway. In addition, the molecular details of the TSC2 




investigation of the effect of single point mutations in residues of TSC2 that are homologous to 
key Ran1GAP residues, may shed more light on the Rheb-TSC2 interactions. This project 
focused on the single point mutation, D74A, in the region adjacent to the GAP catalytic region of 
TSC2 to examine the stabilization and binding effect of this reside on Rheb and TSC2. The 
homologous residue in Ran1GAP showed a decrease in GAP activity and resulted in down-
regulation of GTPase activity in Ran1GTPase. Since this was not observed in TSC2, it was 
hypothesized that D74A could lead to stability of the TSC2-Rheb interaction and induce a more 
stable binding. Several experiments were performed to observe the structural stability of D74A, 
as well as, the interaction Rheb.    
4.1 Characterization Studies of TSC2-218 (WT) and TSC2-218 (D74A) 
According to the circular dichroism spectra, the mutation D74A showed comparable 
secondary structure, specifically alpha-helices, compared to the wild-type. Therefore, the single 
point mutation from aspartic acid to alanine helped in maintaining the protein in primarily an 
alpha helical form with minimal alternations to secondary structure.  
Stability experiments were performed to observe any effect to the protein stability in the 
presence of chemical (urea) and thermal denaturants. The urea denaturation studies showed 
minimal difference in Cm between wild type (3.47M urea) and mutant (3.58M urea). The low 
difference of 0.11M urea between the wild type and variant suggests that the single point 
mutation does not disrupt the stability of the protein in the presence of a chemical denaturant 
(urea).  
Thermal denaturation studies were performed to confirm the effect of the single mutation 
to the protein stability by increasing the temperature of the protein sample. According to the data 




for wild type (69.55°C) and D74A (70.80°C). This corresponds with the findings from the urea 
denaturation studies in that the single point mutation does not affect the stability of the protein.  
Ultimately, the variant seems to have minimal effect on the secondary structure 
(primarily that of alpha helices) and the chemical and thermal protein stability of TSC2-218 
overall, remained quite stable (maybe even slightly more stable) compared to that of the WT.  
4.2 Interaction Studies between RHEB and TSC2-218 (WT and D74A) 
The circular dichroism (CD) difference spectra showed that there was difference between 
the Rheb spectra and the mathematically calculated spectra of TSC2-218 mixture - TSC2-218 for 
both the TSC2-218 WT and D74A samples. This finding implicates that there is binding between 
the variant, D74A, and Rheb as the difference in spectra is caused by the conformational change 
upon TSC2-218 and Rheb due to binding.  
The GTPase activity assay of Rheb in the presence of only 10uM GTP, suggested little 
difference in luminescence (which corresponds to GTP concentration) between high (4uM) and 
low (0uM) concentrations of Rheb (Figure 12). This data confirms the previous findings that the 
intrinsic GTPase properties of Rheb were very low.  
When Rheb was incubated with TSC2-218 WT and D74A, both GAP proteins showed a 
distinct decrease in GTP concentration in comparison to Rheb only group and GTP only group 
(Figure 13). In addition, there was no large difference between the WT and variant TSC2-218 
samples, which confirms that the single point mutation does not diminish its GAP activity 
towards Rheb and thus, Rheb GTPase activity is maintained. Further, in the TSC2-218 
concentration dependent GTPase activity study, it was confirmed that TSC2-218 wild-type and 




and variant in GAP activity. However, the assay would have to be performed with higher 
concentrations of TSC-218 in order to significantly confirm presence of any differences. 
Characterization studies of the interaction between Rheb and TSC2-218 (D74A) have 
shown that the mutation does not seem to diminish the overall ability to bind to Rheb (seen by 
the maintained difference in difference CD spectra) or GAP activity towards Rheb.  
4.3 Future Directions 
In conclusion, this project has detailed preliminary information of TSC2-218 (D74A) in 
terms of stability, secondary structure, GAP stimulated Rheb GTPase activity and qualitative 
binding interactions with Rheb. This information can also be used to draw conclusions on overall 
interactions between Rheb-TSC2. In addition, it is an unique TS2 residue that is able to stabilize 
the interaction with Rheb in comparison to similar mutations in homologous GAP proteins. 
However, more work needs to be done to understand the molecular details of Rheb-TSC2 
binding.  
Since there is limited information on the structure of TSC2, it would be interesting to 
study TSC2 WT and variants using NMR (nuclear magnetic resonance) and/or X-Ray 
crystallography. Though previous attempts have been made to employ NMR to study TSC2, 
obstacles, such as the propensity of TSC2 to aggregate at high concentrations (necessary for 
NMR), have made it difficult to obtain viable data (39). Further attempts need to be made to 
optimize conditions to enable NMR characterization. Alternatively, X-Ray crystallography can 
also be used to derive structural information on wild-type and variant TSC2. 
Further, one of the main goals of studying D74A single mutation is to observe binding 
with Rheb. Since GAP activity is maintained in the variant, it is important to examine the 




binding assays and isothermal titration calorimetry (ITC). In-vitro binding can be performed 
using affinity chromatography and SDS-PAGE and provides qualitative information about 
TSC2-Rheb binding. In contrast, ITC provides quantitative thermodynamic binding data.  
A more comprehensive study of TSC2, wild-type and variant, and molecular details of its 
interaction with Rheb is vital to understanding specific role of D74A in TSC2 and why it does 
not follow the trend of its Ran1GAP homolog. In addition, these findings will also aid in 
shedding light on the specific key residues and general interaction of TSC2 and Rheb. These 
results can also be applied to Ras proteins and their effectors as a whole. Furthermore, 
conclusions from these studies may be used to optimize drug treatments for tuberous sclerosis 
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